Suanzaoren decoction holds potential as a depression treatment by regulating key proteins specific to the Calmodulin-dependent protein kinase signalling pathway in the brain.
In this study, the impact of Suanzaoren decoction (SZRD) on a commonly known 'memory molecule' pathway, the Calmodulin-dependent protein kinases (CaMKs) pathway, was investigated to flush out the mechanism behind its effect on depression-like behavior. A rat model of depression was created by subjecting the animals to chronic unexpected mild stress, before administering SZRD or fluoxetine - an antidepressant, via intragastric methods. Examination of protein and mRNA expression levels of certain elements of the CaMK pathway in the hippocampus, such as CaM, CaMK I, and CaMK IV, was carried out using Western blot, quantitative polymerase chain reaction, and immunohistochemistry techniques, thus revealing the possible interaction between SZRD and the CaMK pathway.
The results of this investigation observed that administration of Suanzaoren decoction resulted in significant improvement in the mood of the rat models demonstrating depressive behavior. An interesting revelation was that the CaMK signaling pathway, and particularly some key proteins within the pathway, were shown to be modulated by the use of SZRD. These findings suggest the potential of SZRD as a depression-treating agent which might operate by influencing the CaMK signaling apparatus in the brain, providing possibilities for improved mood and reduced life pressures.
